Skip to main content

Table 2 Median plasma levels of sCD163 in mg/L (IQR) at 1: last sample before initiation of ART, 2: three months after ART, 3: one year before case’s MI/index date, and 4: last sample before case’s MI/index date

From: Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case–control study

  Sample 1 Sample 2 Sample 3 Sample 4
Cases 3.22 2.87 2.33 2.38
(2.53 – 4.32) (2.22 – 3.51) (1.73 – 3.31) (1.86 – 3.58)
n = 51 n = 49 n = 51 n = 55
Controls 3.03 2.68 2.24 2.24
(2.50 – 4.58) (2.13 – 3.70) (1.65 – 2.98) (1.69 – 2.99)
n = 165 n = 161 n = 172 n = 176
p – valuesa 0.67 0.48 0.66 0.08
  1. a univariate conditional logistic regression.